Clinical Trial Update: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 double-blind trial evaluating two doses of an investigational product for 16 weeks in adults with non-alcoholic steatohepatitis and type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Investigational product

Snippet

Sponsor: Pfizer | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2022-05-11